Literature DB >> 6290057

Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.

A Goldhirsch, R Joss, F Cavalli, K W Brunner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290057     DOI: 10.1016/s0305-7372(82)80084-4

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy advances in small-cell lung cancer.

Authors:  Bryan A Chan; Jermaine I G Coward
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma.

Authors:  A Veronesi; V Zagonel; M Santarossa; U Tirelli; E Galligioni; M G Trovo'; S Tumolo; E Grigoletto
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Prognostic effects of osteoclast inhibitors in extensive stage small cell lung cancer patients with bone metastases.

Authors:  Atsushi Mitsuhashi; Yusuke Okuma; Yoshitaka Zenke; Yukio Hosomi
Journal:  Mol Clin Oncol       Date:  2018-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.